1 The loop diuretic furosemide is known to antagonize the function of g-aminobutyric acid type A (GABA A ) receptors. The purpose of the present study was to examine the direct interaction of furosemide with the GABA A receptors by autoradiography and ligand binding studies with native rat and human receptors and with recombinant receptors composed of rat subunits. 35 S]-TBPS binding by furosemide in the absence of GABA. However, it failed to aect the GABA-antagonism of furosemide, suggesting that the enhancement of basal binding and the GABA antagonism might represent two dierent allosteric actions of furosemide. 6 In conclusion, the present results indicate that furosemide is a subtype-selective GABA A antagonist with a mode of action not shared by several other antagonists, which makes furosemide a unique compound for development of potential GABA A receptor subtype-speci®c and -selective ligands.
Introduction
The main central nervous system inhibitory neurotransmitter receptor, g-aminobutyric acid type A (GABA A ) receptor, mediates, at least partly, behavioral actions of a number of important drugs, including benzodiazepine receptor ligands, barbiturates, anaesthetics and possibly ethanol (LuÈ ddens et al., 1995; Sieghart, 1995) . This receptor shows enormous molecular heterogeneity, being a pentameric complex of 13 subunits, which belong to a (members 1 ± 6), b (1 ± 3), g (1 ± 3) or d (1) classes (Olsen & Tobin, 1990; Stephenson, 1995) . It also shows brain regional heterogeneity due to cell-speci®c expression of dierent subunits Persohn et al., 1992; . In spite of this heterogeneity, only a few compounds have been discovered which display some receptor subtype selectivity. All these compounds, such as the hypnotic benzodiazepine receptor ligand, zolpidem ) and the antiepileptics, carbamazepine and phenytoin (Granger et al., 1995) , show selectivity towards the main receptor subtype containing the a1 subunit.
We have recently discovered that the Na + /2 Cl 7 /K + cotransporter blocker furosemide (Greger & Wangemann, 1987) selectively, reversibly, rapidly and noncompetitively antagonizes Cl 7¯u x in a cerebellar granule cell-speci®c GABA A receptor subtype (IC 50 about 10 mM in a6b2g2 receptors; Korpi et al., 1995a) . This antagonism was not due to transporter blockade, since another diuretic with similar speci®city for the Na + /2 Cl 7 /K + co-transporter, bumetanide, was inactive. The furosemide eect depended on the interplay between a6 and b2 or b3 subunits in GABA A abg receptors. The purpose of the present study was to clarify further the pharmacology of furosemide interaction with the GABA A receptor by studying both native and recombinant receptors in the presence of known GABA A antagonists SR 95531 (Heaulme et al., 1986) , Ro 5-4864 (Weissman et al., 1984) and clozapine (Korpi et al., 1995b) . In addition, we excluded other brain regions as showing similar kind of furosemide antagonism by ligand autoradiography, speci®cally in hippocampal and thalamic regions.
Methods

Brain samples and membranes
Four-month-old male Wistar rats (Department of Animal Physiology, University of Helsinki, Helsinki, Finland) were decapitated and the cerebral cortex and cerebellum were dis-sected and frozen. For autoradiography, whole brains were carefully dissected and frozen on dry ice. Human cerebellar cortical samples were from autopsies at the District of Columbia Medical Examiner's Oce from four control subjects used earlier in a benzodiazepine binding study (mean age 47.5 years (range 38 ± 59), 3 males, 1 female, postmortem interval 25 h (range 17 ± 31), all with negative postmortem toxicology screen, cardiovascular diseases causing their deaths; Korpi et al., 1992b) . The tissues were homogenized with a Polytron in 50 volumes of ice-cold 50 mM Tris-citrate buer (pH 7.4) supplemented with 1 mM disodium edetate, centrifuged at 20,000 x g for 20 min. The pellets were resuspended in the same buer and recentrifuged 5 times. The ®nal suspension was prepared in 50 mM Tris-citrate buer and stored frozen, in aliquots, at 780 8C.
Recombinant receptors
Human embryonic kidney (HEK) 293 cells were transfected (Chen & Okayama, 1987) with rat cDNAs encoding a6, b3, g2S and d subunits, subcloned individually into eukaryotic expression vectors Ymer et al., 1989; Shivers et al., 1989; LuÈ ddens et al., 1990) . Quantitative ratios of the cDNAs for the a6, b3, g2S and d subunits were 5:3:0.5:5. Brie¯y, cells plated on dishes 15 cm in diameter (Becton Dickinson Labware, Lincoln Park, NJ) were transfected two to three days later. About 20 h after transfection, the medium was changed, and 48 h after transfection, the cells were washed and harvested in phosphate-buered saline. Cell pellets were homogenized with a Polytron in 50 mM Tris-citrate (pH 7.4) buer, centrifuged, resuspended, and stored frozen at 780 8C.
Ligand binding
Frozen membranes were thawed, resuspended and centrifuged once, before ®nal resuspension in 50 mM Tris-citrate to give a protein concentration of 20 ± 240 mg ml 71 (Bio-Rad Protein Assay kit) in a total volume of 0.5 ml per assay tube (Korpi & LuÈ ddens, 1993) . After de®ned incubation times of duplicate samples, bound and free ligands were separated by rapid ®l-tration of the membranes onto Schleicher & Schuell #52 or Whatman GF/B glass ®bre ®lters. Samples were rinsed twice with 5 ml of ice-cold 10 mM Tris-HCl (pH 7.4). The air-dried ®lters were immersed in 4 ml of scintillation¯uid and their radioactivity was determined.
[ 
Autoradiography
The procedure (Korpi et al., 1995b) used was modi®ed from and Edgar & Schwartz (1990) . Brie¯y, 14 mm frontal sections were cut in a Leitz 1720 cryostat at the following levels (in mm) from the bregma according to Paxinos & Watson (1982): 7, 2.7, 1.5, 70.8, 71.8, 73.3, 75.3, 76.3, 78.5, and 710.3 Figure 1 .
Statistics
Statistical signi®cance of the dierences from the corresponding control binding and between two population means was assessed by use of two-tailed Student's t test with Instat program (GraphPad Software, San Diego, CA).
Results
We used the modulation of the convulsant binding site labelled by [ 35 S]-TBPS as a biochemical test for GABA A receptor function, since in the presence of GABA this site is allosterically modulated by other ligands in a manner predictive for agonistic and antagonistic ecacy (see Korpi et al., 1995b) . Quantitative autoradiography of [ (Table 1 ). Since it has been shown that furosemide antagonizes a part of the hippocampal GABA A response in electrophysiological studies (Pearce, 1993) , we looked more carefully at this brain region in the presence of various furosemide concentrations (Figure 1) Figure 1 ), such as medial geniculate nucleus, known to contain a4 subunits which make furosemide-sensitive receptors when expressed recombinantly with b2 and g2 subunits (Kno¯ach et al., 1996) . Cerebellar membranes from postmortem human normal control subjects were used to ascertain whether furosemide antagonism is present also in human cerebellum. Similar to rat cerebellar membranes (Korpi et al., 1995a) , furosemide reversed the GABA-inhibition of [ 35 S]-TBPS binding, although the binding was not clearly enhanced by it in the absence of GABA (Figure 2) .
In addition to speci®c GABA antagonism in the cerebellar granule cell layer, furosemide at high micromolar and low millimolar concentrations decreased the binding of [ 35 S]-TBPS to cerebellar, hippocampal and cerebrocortical membranes (Korpi et al., 1995a) . In agreement, 1 mM furosemide signi®cantly decreased the binding in selected brain regions in the absence of added GABA (Table 1) , and further enhanced the GABA-inhibition of the binding in most brain regions. Unlike the action of furosemide on the cerebellar granule cell receptors, the`displacing' action was also shared with another diuretic, bumetanide (Korpi et al., 1995a ; quantitative data not shown).
Representatives of two dierent classes of GABA A antagonists, SR 95531 and Ro 5-4864, were found to reverse the furosemide-induced elevation of [ (Figure 6a ). It also antagonized GABA-inhibition of the binding irrespective of furosemide. In recombinant GABA A a6b3g2 receptors, clozapine still slightly aected the binding in the absence of GABA, but failed to aect the GABA-inhibition of the binding and furosemide antagonism of GABA-inhibition (Figure 6b ).
Co-transfection of human embryonic kidney 293 cells with a6, b3, g2 and d subunit combinations revealed that the action of furosemide was independent of the g variant in the receptor complex ( Table 2 ). The inhibition of [ 35 S]-TBPS binding to a6b3 as well as a6b3d receptors by 10 mM GABA was reversed by 300 mM furosemide, indicating that the a6b3 is sucient for the expression of the furosemide recognition site on GABA A receptors. However, furosemide without GABA did not increase the binding above control levels in a6b3 or a6b3d receptors in contrast to a6b3g2 receptors (Table 2 ; Korpi et al., 1995a) .
Discussion
The present results indicate several interesting novel features in the mode of the interaction of furosemide with the GABA A receptor: (1) it shows a selective antagonism at cerebellar granule cell-speci®c receptors, dependent on the a6 and b3 subunits whether accompanied or not by g2 or d subunits, (2) a similar kind of antagonism by furosemide is undetectable in hippocampal and thalamic regions, in spite of its selective attenuation of a receptor response in hippocampus (Pearce, 1993) and of the sensitivity of a4b2g2 receptors to furosemide (Kno¯ach et al., 1996) , (3) Cerebellar granule cells are a unique locus for`diazepaminsensitivity' of benzodiazepine binding sites (Sieghart et al., 1987; Malminiemi & Korpi, 1989) and for high GABA sensitivity of [
35 S]-TBPS binding sites (Korpi & LuÈ ddens, 1993) , both properties being dependent on the presence of the GABA A receptor a6 subunit in abg receptors (LuÈ ddens et al., 1990; Korpi & LuÈ ddens, 1993) . Obviously due to the high GABA sensitivity, the binding of [ 35 S]-TBPS or related ionophore ligands to the granule cell GABA A receptors increases in the presence of receptor antagonists, such as SR 95531, bicuculline, RU 3156 and Ro 5-4864 (Korpi et al., 1992a; Sapp et al., 1992; Sakurai et al., 1994) . However, the action of furosemide on GABA A receptors seems to be dierent from that of the other antagonists, because it elevates the binding above basal levels also in the absence, as well as presence, of exogenous GABA in native cerebellar and in recombinant a6b2/3g2 receptors (Korpi et al., 1995a; LuÈ ddens & Korpi, 1995) . The furosemide action in the absence of exogenous GABA, re¯ecting an increased [ 35 S]-TBPS binding af®nity (Korpi et al., 1995a) , was readily reversed by SR 95531 and clozapine (Figures 3 and 6) , suggesting that it is produced by a rather weak allosteric modi®cation of the a6 subunitcontaining receptor. Furthermore, SR 95531 and especially clozapine, which in itself is not able to antagonize a6b2/3g2 receptors (Korpi et al., 1995b) , could not block the furosemide antagonism of GABA action in native or recombinant receptors, suggesting a dierent mechanism of action for furosemide in the absence and presence of GABA. Our present experiments indicate that the GABA antagonism by furosemide only requires the a6 and b3 subunits. The latter variant most likely can be replaced by the b2, but not by the b1 subunit. The interaction of furosemide took place in a6b3 double and in a6b3g2 and a6b3d triple combinations. However, the elevation of [
35 S]-TBPS binding without GABA could not be seen in any combination other than a6b3g2 receptors, again indicating that furosemide produces at least two dierent alterations in the GABA A receptor conformation. The enhancement of basal binding by furosemide was not clearly detectable in human cerebellar membranes. One way to interprete these data is that the d subunit is prominently assembled with a6 and b2/3 subunits, even if a6b2/3g2 receptors must be present as they are responsible for the`diazepaminsensitive' benzodiazepine binding of the human cerebellum (Turner et al., 1991; Korpi et al., 1992b) .
The picrotoxin-sensitive [
35 S]-TBPS binding assay used in the present study did not reveal any GABA-antagonism by furosemide in the hippocampus, although electrophysiological studies have clearly demonstrated the presence of a component sensitive to high micromolar concentrations of furosemide in that region (Pearce, 1993) . Since furosemide at high concentrations (0.3 ± 1 mM) slightly decreases [ 35 S]-TBPS binding in many brain regions (Korpi et al., 1995a;  Table 1 ), it is possible that it antagonizes the receptor channel through the picrotoxin site. In this way furosemide could reduce GABA A responses in non-a6 and non-a4 containing receptors, such as in a1b2g2 receptors (IC 50 about 3000 mM; Korpi et al., 1995a) . Further experiments are needed to establish the action on the picrotoxin-site as an additional mechanism for rapid GABA A antagonism by high furosemide concentrations. Our autoradiographic data showing no furosemide-induced GABA A receptor antagonism in the hippocampus and thalamus also indicate that the proportion of a4 subunit-containing receptors is very low, even if its mRNA is abundant in these regions .
The convulsant benzodiazepine derivative Ro 5-4864, which does not bind to the classical benzodiazepine site of the GABA A receptors (Weissman et al., 1985; Basile et al., 1989) , had a biphasic interaction on [ 35 S]-TBPS binding in cerebellar and cerebrocortical membranes, being directionally opposite in the presence and absence of exogenous GABA (Gee, 1987 ; Figure 3 ). Only high micromolar Ro 5-4864 concentrations were eective in attenuating or blocking the eects of furosemide in cerebellar, but not cerebrocortical membranes. Although furosemide inhibited the high-anity [
3 H]-Ro 5-4864 binding in both brain regions, the [ 3 H]-Ro 5-4864 binding measured under these conditions detects mitochondrial peripheral-type benzodiazepine receptors known to be poorly sensitive to furosemide (IC 50 =85 to41000 mM; Lukeman & Fanestil, 1987; Basile et al., 1988) . Although our experiments cannot fully exclude the involvement of the low-anity Ro 5-4864 binding sites on the GABA A receptor in the subtypeselective antagonism by furosemide, it is likely that furosemide acts via (an)other site(s), since the subunit requirements for Ro 5-4864 ecacy are much broader than those for furosemide, and independent of the a6 subunit (Puia et al., 1989) .
In conclusion, the present data support the idea of selective antagonism of a cerebellar granule cell GABA A receptor population by furosemide via a novel kind of direct interaction with the receptor subunits. This speci®c interaction can be used to de®ne the physiological functions of a6 subunit-containing GABA A receptors (see Zhu et al., 1995; Tia et al., 1996) , since nonselective actions of furosemide on neuronal excitation (Hochman et al., 1995) and GABA A receptor function (Thompson et al., 1988; Zhang et al., 1991) need either high concentrations, longer periods of action or are nonspeci®cally shared by other Na + /2 Cl 7 /K + co-transporter blockers.
